Cooperman Leon G’s DiaMedica Therapeutics DMAC Stock Holding History

Cooperman Leon G’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.3M	Buy	3,450,000 +1,430,000	+71%	+$8.79M	0.68%	27
2026 Q1	$13.7M	Hold	2,020,000	–	–	0.45%	30
2025 Q4	$16.1M	Sell	2,020,000 -1,249,761	-38%	-$9.35M	0.53%	30
2025 Q3	$17.6M	Buy	3,269,761 +1,619,761	+98%	+$8.79M	0.55%	30
2025 Q2	$6.43M	Buy	1,650,000 +25,000	+2%	+$97.5K	0.23%	31
2025 Q1	$6.16M	Hold	1,625,000	–	–	0.24%	30
2024 Q4	$8.82M	Buy	1,625,000 +113,261	+7%	+$534K	0.33%	30
2024 Q3	$6.33M	Buy	1,511,739 +111,739	+8%	+$413K	0.27%	29
2024 Q2	$4.13M	Buy	1,400,000 +516,377	+58%	+$1.42M	0.17%	32
2024 Q1	$2.45M	Hold	883,623	–	–	0.1%	36
2023 Q4	$2.51M	Buy	883,623 +7,630	+0.9%	+$18.9K	0.12%	36
2023 Q3	$2.26M	Hold	875,993	–	–	0.12%	38
2023 Q2	$3.78M	Buy	875,993 +7,580	+0.9%	+$18.4K	0.21%	34
2023 Q1	$1.33M	Buy	868,413 +55,905	+7%	+$88.7K	0.08%	39
2022 Q4	$1.28M	Hold	812,508	–	–	0.08%	40
2022 Q3	$1.01M	Hold	812,508	–	–	0.07%	41
2022 Q2	$1.64M	Hold	812,508	–	–	0.11%	38
2022 Q1	$2.03M	Buy	812,508 +512,508	+171%	+$1.45M	0.11%	41
2021 Q4	$1.12M	Buy	300,000 +100,000	+50%	+$393K	0.06%	49
2021 Q3	$802K	Buy	200,000 +150,000	+300%	+$574K	0.04%	50
2021 Q2	$223K	Hold	50,000	–	–	0.01%	62
2021 Q1	$458K	Buy	50,000 +20,000	+67%	+$187K	0.03%	45
2020 Q4	$304K	Buy	+30,000	New	+$164K	0.02%	43

Other funds holding DMAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cooperman Leon G's DMAC Position: Q2 2026 in Review

Cooperman Leon G increased its DiaMedica Therapeutics (DMAC) stake by 71% in Q2 2026, buying an estimated $8.79M and bringing the position to 3,450,000 shares worth $24.3M. The position accounts for 0.68% of the portfolio, ranked #27.

Cooperman Leon G first reported a position in DMAC in Q4 2020 and has held it in 23 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

Cooperman Leon G held 3,450,000 shares of DiaMedica Therapeutics worth $24.3M as of Q2 2026.
Cooperman Leon G bought 1,430,000 DiaMedica Therapeutics shares in Q2 2026, an estimated $8.79M.
DiaMedica Therapeutics made up 0.68% of Cooperman Leon G's portfolio in Q2 2026, its #27 holding.
Cooperman Leon G first reported a position in DiaMedica Therapeutics in Q4 2020 and has held it in 23 quarters since.
89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Cooperman Leon G's 13F filing for Q2 2026, filed 14 Aug 2026.